NO20040174L - Fremgangsmate for donorspesifikk krysstilpasning - Google Patents

Fremgangsmate for donorspesifikk krysstilpasning

Info

Publication number
NO20040174L
NO20040174L NO20040174A NO20040174A NO20040174L NO 20040174 L NO20040174 L NO 20040174L NO 20040174 A NO20040174 A NO 20040174A NO 20040174 A NO20040174 A NO 20040174A NO 20040174 L NO20040174 L NO 20040174L
Authority
NO
Norway
Prior art keywords
donor
matching
procedure
specific cross
specific
Prior art date
Application number
NO20040174A
Other languages
English (en)
Inventor
Suchitra Sumitran-Holgersson
Original Assignee
Absorber Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Absorber Ab filed Critical Absorber Ab
Publication of NO20040174L publication Critical patent/NO20040174L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G01N2800/245—Transplantation related diseases, e.g. graft versus host disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
NO20040174A 2002-05-16 2004-01-15 Fremgangsmate for donorspesifikk krysstilpasning NO20040174L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38103302P 2002-05-16 2002-05-16
PCT/IB2003/002502 WO2003098212A2 (en) 2002-05-16 2003-05-16 Method of isolating an endotehelial cell and method of donor specific crossmatching

Publications (1)

Publication Number Publication Date
NO20040174L true NO20040174L (no) 2004-03-08

Family

ID=29550055

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040174A NO20040174L (no) 2002-05-16 2004-01-15 Fremgangsmate for donorspesifikk krysstilpasning

Country Status (17)

Country Link
US (3) US8173372B2 (no)
EP (1) EP1458853B1 (no)
AT (1) ATE449838T1 (no)
AU (1) AU2003241107B2 (no)
BR (1) BRPI0311182A2 (no)
CA (1) CA2486119C (no)
CY (1) CY1109815T1 (no)
DE (1) DE60330223D1 (no)
DK (1) DK1458853T3 (no)
ES (1) ES2337244T3 (no)
IL (2) IL165250A0 (no)
NO (1) NO20040174L (no)
NZ (1) NZ537220A (no)
PL (2) PL397820A1 (no)
PT (1) PT1458853E (no)
SI (1) SI1458853T1 (no)
WO (1) WO2003098212A2 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8980568B2 (en) 2001-10-11 2015-03-17 Aviva Biosciences Corporation Methods and compositions for detecting non-hematopoietic cells from a blood sample
US8986944B2 (en) 2001-10-11 2015-03-24 Aviva Biosciences Corporation Methods and compositions for separating rare cells from fluid samples
NZ537220A (en) * 2002-05-16 2008-06-30 Absorber Ab Method of isolating an endothelial cell and method of donor specific crossmatching
CA2657621A1 (en) 2006-07-14 2008-01-17 Aviva Biosciences Corporation Methods and compositions for detecting rare cells from a biological sample
EP2051076A1 (en) * 2007-10-18 2009-04-22 Koninklijke Philips Electronics N.V. Interaction of probe molecules and cells as a diagnostic marker
KR20220131293A (ko) 2020-01-24 2022-09-27 화이자 인코포레이티드 항-e-셀렉틴 항체, 조성물 및 사용 방법

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4353888A (en) 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
NO155316C (no) 1982-04-23 1987-03-11 Sintef Fremgangsmaate for fremstilling av magnetiske polymerpartikler.
US4965204A (en) 1984-02-06 1990-10-23 The Johns Hopkins University Human stem cells and monoclonal antibodies
US5130144B1 (en) 1984-02-06 1995-08-15 Univ Johns Hopkins Human stem cells and monoclonal antibodies
US4714680B1 (en) * 1984-02-06 1995-06-27 Univ Johns Hopkins Human stem cells
US5026365A (en) 1987-04-29 1991-06-25 The University Of Massachusetts Method and apparatus for therapeutically treating immunological disorders and disease states
ATE81724T1 (de) 1987-11-09 1992-11-15 Becton Dickinson Co Verfahren zur analyse haematopoietischer zellen in einer probe.
US5158881A (en) 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
US5283187A (en) 1987-11-17 1994-02-01 Brown University Research Foundation Cell culture-containing tubular capsule produced by co-extrusion
US5071741A (en) 1988-04-18 1991-12-10 Cryolife, Inc. Cryoprotective agent and its use in cryopreservation of cellular matter
DE3829766A1 (de) 1988-09-01 1990-03-22 Akzo Gmbh Verfahren zur herstellung von membranen
DE3829752A1 (de) 1988-09-01 1990-03-22 Akzo Gmbh Integrale asymmetrische polyaethersulfonmembran, verfahren zur herstellung und verwendung zur ultrafiltration und mikrofiltration
US5084350A (en) 1990-02-16 1992-01-28 The Royal Institution For The Advance Of Learning (Mcgill University) Method for encapsulating biologically active material including cells
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5283058A (en) 1990-08-30 1994-02-01 The General Hospital Corporation Methods for inhibiting rejection of transplanted tissue
SG47470A1 (en) 1991-04-25 1998-04-17 Univ Brown Res Found Implantable biocompatible immunoisolatory vehicle for delivery of a selected therapeutic products
US5257984A (en) 1991-10-02 1993-11-02 Norfolk Scientific, Inc. Blood collector
US5955291A (en) * 1992-01-09 1999-09-21 Alitalo; Kari Antibodies recognizing tie receptor tyrosine kinase and uses thereof
IL104470A0 (en) 1992-01-21 1993-05-13 Cryopharm Corp Process for freezing cells and cell like materials and compositions prepared thereby
US5518890A (en) 1992-11-20 1996-05-21 Mccormick & Company, Inc. Method and apparatus for the quantitation and separation of contaminants from particulate materials
ES2178654T3 (es) 1993-08-12 2003-01-01 Neurotech Sa Capsulas biocompatibles inmonoaisladoras que contienen celulas geneticamente alteradas para el suministro de moleculas biologicamente activas.
US5518878A (en) 1993-09-15 1996-05-21 Organogenesis Inc. Cryopreservation of cultured skin or cornea equivalents with agitation
US5482841A (en) 1994-05-24 1996-01-09 Sangstat Medical Corporation Evaluation of transplant acceptance
US6017719A (en) * 1994-06-14 2000-01-25 Nexell Therapeutics, Inc. Positive and positive/negative cell selection mediated by peptide release
US5840502A (en) * 1994-08-31 1998-11-24 Activated Cell Therapy, Inc. Methods for enriching specific cell-types by density gradient centrifugation
US5580714A (en) 1995-03-08 1996-12-03 Celox Laboratories, Inc. Cryopreservation solution
US5629145A (en) 1995-03-24 1997-05-13 Organ, Inc. Cryopreservation of cell suspensions
KR0176513B1 (ko) * 1995-04-13 1999-04-15 김광호 자기 기록/재생장치
US5942385A (en) * 1996-03-21 1999-08-24 Sugen, Inc. Method for molecular diagnosis of tumor angiogenesis and metastasis
US5843633A (en) * 1996-04-26 1998-12-01 Amcell Corporation Characterization of a human hematopoietic progenitor cell antigen
WO1998014058A1 (en) 1996-10-03 1998-04-09 The Regents Of The University Of California Cryopreservation of human adult and fetal pancreatic cells and human platelets
US6103536A (en) 1997-05-02 2000-08-15 Silver Lake Research Corporation Internally referenced competitive assays
EP0893493A3 (de) * 1997-07-21 2002-12-04 Aventis Pharma Deutschland GmbH Genetisch veränderte Zellen und deren Verwendung in der Prophylaxe oder Therapie von Erkrankungen
US20030100107A1 (en) 1998-05-29 2003-05-29 Thomas Jefferson University Compositions and methods for generating differentiated human cells
US6376653B1 (en) 1998-09-28 2002-04-23 Smithkline Beecham Plc Tie2 antagonist antibodies
US6197294B1 (en) 1998-10-26 2001-03-06 Neurotech S.A. Cell surface molecule-induced macrophage activation
US6309643B1 (en) 1999-04-30 2001-10-30 The Regents Of The University Of California IBD-associated microbial antigens and methods of using same
GB0015923D0 (en) * 2000-06-30 2000-08-23 Astrazeneca Ab Methods
US6984308B2 (en) * 2001-03-06 2006-01-10 Cincinnati Children's Hospital Research Foundation Electrochemical analysis of coenzyme Q10 and reduced coenzyme Q10
US20050026220A1 (en) * 2001-08-10 2005-02-03 Shahin Rafii Isolation and mobilization of stem cells expressing vegfr-1
WO2003062373A2 (en) * 2001-10-18 2003-07-31 The Children's Hospital Of Philadelphia Methods and materials for the recruitment of endothelial cells
NZ537220A (en) * 2002-05-16 2008-06-30 Absorber Ab Method of isolating an endothelial cell and method of donor specific crossmatching
JP2008509678A (ja) * 2004-08-13 2008-04-03 メドトロニック・インコーポレーテッド 内皮前駆細胞サブセットの単離とそれらの使用方法

Also Published As

Publication number Publication date
US20030228638A1 (en) 2003-12-11
US20050244404A1 (en) 2005-11-03
ATE449838T1 (de) 2009-12-15
PT1458853E (pt) 2010-02-23
PL397820A1 (pl) 2012-07-16
WO2003098212A2 (en) 2003-11-27
CA2486119C (en) 2011-01-04
DK1458853T3 (da) 2010-04-06
US8034635B2 (en) 2011-10-11
US20090142780A1 (en) 2009-06-04
DE60330223D1 (no) 2010-01-07
EP1458853A2 (en) 2004-09-22
SI1458853T1 (sl) 2010-04-30
AU2003241107A1 (en) 2003-12-02
ES2337244T3 (es) 2010-04-22
US8173372B2 (en) 2012-05-08
PL373564A1 (en) 2005-09-05
EP1458853B1 (en) 2009-11-25
WO2003098212B1 (en) 2004-07-29
CY1109815T1 (el) 2014-09-10
PL212661B1 (pl) 2012-11-30
CA2486119A1 (en) 2003-11-27
IL165250A0 (en) 2005-12-18
IL165250A (en) 2011-03-31
WO2003098212A3 (en) 2004-07-01
BRPI0311182A2 (pt) 2016-06-21
NZ537220A (en) 2008-06-30
AU2003241107B2 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
DE60232234D1 (de) Verfahren zur kultivierung von circovirus
EP1660653A4 (en) BIODEGRADABLE POLYMER-LIGAND CONJUGATES AND THEIR USES IN THE ISOLATION OF CELLULAR SUB-POPULATIONS AND IN THE CYNOSINATION, CULTURE AND TRANSPLANTATION OF CELLS
NO20030856D0 (no) Membranpenetrerende peptider og anvendelse av disse
NO20033396D0 (no) Forbedret in vitro fremgangsmåte for kultivering av mammale celler for autolog celle implantasjon/transplantasjon fremgangsmåter
WO2004096975A3 (en) Apparatus and methods for amplification of blood stem cell numbers
EP2471903A3 (en) Placental stem cell populations
ZA200509760B (en) Composition for maintaining organ and cell viability
CY1109815T1 (el) Μεθοδοι διασταυρουμενης συμβατοτητας ειδικες δοτη
CY1111769T1 (el) Παρασκευη κυτταρων
WO2006127809A3 (en) Methods for expansion and analysis of cultured hematopoietic stem cells
EP1769066A4 (en) MODIFIED ANTIGEN PRESENTING CELLS
DE60307615D1 (de) Zellkulturmedium
WO2004013288A3 (en) Methods and kits for synthesis of sirna expression cassettes
DE60323267D1 (en) Rna-bioassay
WO2004016743A3 (en) Culturing anaplasma
ATE423842T1 (de) Isolation der endothelvorläuferzellen-untermengen und verfahren zu ihrer verwendung
EP1283727A4 (en) COMPOSITIONS AND METHODS FOR INDUCING ACTIVATION OF DENTRIC CELLS
WO2005042732A3 (en) STABLE CELL LINES EXPRESSING HERG1a AND HERG1b
WO2003087305A3 (en) Methods and compositions for anchoring stem cells in a microenvironment
EP1303287A4 (en) MHC PEPTIDES OVEREXPRESSED IN PROSTATE CANCER CELL AND METHODS FOR THEIR USE
EP1812063A4 (en) MONOCLONAL ANTIBODIES AGAINST THE CANDIDA ALBICANS PROPEPTIDE AND METHOD OF USE
WO2004096972A3 (en) Apparatus and methods for amplification of blood stem cell numbers
SE0103878D0 (sv) Device used in cell culturing
GEP20084444B (en) Method of obtaining cell lines in a protein-free medium and cell lines thus obtained
GB0201477D0 (en) Methods of obtaining isoform specific expression in mammalian cells

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application